Deterioration of cartilage in adults due to trauma or disease is a major health issue in industrialized nations. Because cartilage lacks a regenerative ability, the therapeutic approach of creating cartilage implants in vitro has recently been put forward. Mesenchymal stem cells (MSCs) are promising candidate cells for cartilage tissue engineering. However, using MSCs for the articular cartilage repair faces a challenge of generating cells with features of stable chondrocytes which are resistant to hypertrophy and terminal differentiation. Prevention of chondrocyte hypertrophy is necessary to avoid vascularization and ossification of the cartilage implants. Chondrocyte differentiation to hypertrophy is regulated by multiple factors, including tissue transglutaminase (TG2). Up-regulation of TG2 in inflamed joints suggests that it may affect the stability of the cartilage implant engineered from mesenchymal cells. We have observed that TG2 is up-regulated during chondrogenic differentiation of the chicken limb bud mesenchymal cells. Moreover, excess TG2 reduces deposition on cartilaginous matrix in differentiating mesenchymal micromass cultures and deregulates proper development of the growth plate in embryo. We hypothesize that TG2 is a key regulator of cartilage formation. The objective of this proposal is to investigate the mechanism by which TG2 regulates chondrogenesis in vitro. We will test our hypothesis by pursuing three Specific Aims. (1) We will identify which stage of chondrogenic differentiation is affected by TG2 in vitro. For this we will analyze expression of the stage- specific markers of chondrocyte differentiation. (2) We will define the signaling pathway(s) which mediate regulation of chondrogenesis by TG2. Here, we will test the hypothesis that 2-catenin signaling plays the key role in the TG2-dependent regulation of chondrogenic differentiation of mesenchymal cells. These studies will be performed using biochemical assays and pharmacological inhibitors of 2- catenin. (3) We propose to analyze the requirement for trans-amidating activity of TG2 in regulation of chondrogenesis, using pharmacological inhibitors of TG2 and the already existing viral constructs for overexpression of both the wild-type and catalytically inactive forms of TG2. The long-term goal of our research is to characterize the molecular mechanisms that govern cartilage formation both in vivo and in vitro in order to direct and maintain differentiated chondrocyte phenotype and to provide approaches for treating arthritis and other skeletal diseases.

Public Health Relevance

Deterioration of cartilage due to trauma or disease, most notably arthritis, affects over 20% of adults in United States, and the frequency of this pathology is projected to further increase with the aging of population. Healing of damaged cartilage is extremely inefficient, therefore creating cartilage implants in vitro has recently been put forward as a promising therapeutic approach. The goal of this study is to characterize the molecular mechanisms that govern cartilage formation both in vivo and in vitro, and thus to provide molecular tools for bioengineering of robust and stable cartilage implants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Small Research Grants (R03)
Project #
1R03AR057126-01
Application #
7644225
Study Section
Special Emphasis Panel (ZAR1-EHB-D (M1))
Program Officer
Tyree, Bernadette
Project Start
2009-09-09
Project End
2011-08-31
Budget Start
2009-09-09
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$75,000
Indirect Cost
Name
University of Maryland Baltimore
Department
Biochemistry
Type
Schools of Medicine
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Beazley, Kelly E; Nurminskaya, Maria (2014) BMP2 cross-linked by transglutaminase 2 to collagen-plla scaffold promotes osteogenic differentiation in mesenchymal stem cells. Biotechnol Lett 36:1901-7
Eckert, Richard L; Kaartinen, Mari T; Nurminskaya, Maria et al. (2014) Transglutaminase regulation of cell function. Physiol Rev 94:383-417
Niger, Corinne; Beazley, Kelly E; Nurminskaya, Maria (2013) Induction of chondrogenic differentiation in mesenchymal stem cells by TGF-beta cross-linked to collagen-PLLA [poly(L-lactic acid)] scaffold by transglutaminase 2. Biotechnol Lett 35:2193-9
Nurminskaya, Maria V; Belkin, Alexey M (2012) Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol 294:1-97
Lin, Xinhua; Shanmugasundaram, Shobana; Liu, Yi et al. (2012) B2A peptide induces chondrogenic differentiation in vitro and enhances cartilage repair in rats. J Orthop Res 30:1221-8
Deasey, Stephanie; Grichenko, Olga; Du, Shaojun et al. (2012) Characterization of the transglutaminase gene family in zebrafish and in vivo analysis of transglutaminase-dependent bone mineralization. Amino Acids 42:1065-75
Shanmugasundaram, Shobana; Logan-Mauney, Sheila; Burgos, Kaitlin et al. (2012) Tissue transglutaminase regulates chondrogenesis in mesenchymal stem cells on collagen type XI matrices. Amino Acids 42:1045-53
Deasey, Stephanie; Shanmugasundaram, Shobana; Nurminskaya, Maria (2011) Tissue-specific responses to loss of transglutaminase 2. Amino Acids :
Nurminsky, Dmitry; Shanmugasundaram, Shobana; Deasey, Stephanie et al. (2011) Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech Dev 128:234-45